{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:47:10Z","timestamp":1791737230851,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"DOI":"10.1007\/s00066-026-02614-0","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:35:43Z","timestamp":1791736543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of PET-detected nodal upstaging and planning target volume expansion in esophageal cancer radiotherapy planning"],"prefix":"10.1007","author":[{"given":"Sanyamita","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0977-6935","authenticated-orcid":false,"given":"Akash R.","family":"Bellige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarthak","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Bhadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parveen","family":"Ahlawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munish","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"issue":"12","key":"2614_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57121334","volume":"57","author":"M Slavik","year":"2021","unstructured":"Slavik M, Burkon P, Selingerova I, Krupa P, Kazda T, Stankova J, et al (2021) Preoperative Chemoradiotherapy for Gastroesophageal Junction Adenocarcinoma Modified by PET\/CT: Results of Virtual Planning Study. Medicina (Kaunas) 57(12):1334. https:\/\/doi.org\/10.3390\/medicina57121334 PubMed PMID: 34946279; PubMed Central PMCID: PMC8705963.","journal-title":"Medicina (Mex)"},{"key":"2614_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.radonc.2020.11.032","volume":"156","author":"M Thomas","year":"2021","unstructured":"Thomas M, Mortensen HR, Hoffmann L, M\u00f8ller DS, Troost EGC, Muijs CT, et al (2021) Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer. Radiotherapy and Oncology 156:102\u201312. https:\/\/doi.org\/10.1016\/j.radonc.2020.11.032","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"6","key":"2614_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15060690","volume":"15","author":"A Secerov-Ermenc","year":"2025","unstructured":"Secerov-Ermenc A, Peterlin P, Velenik V, Jeromen-Peressutti A, But-Hadzic J, Anderluh F, et al (2025) PET\/CT and MR Improve Interobserver Agreement in Primary Tumor Determination for Radiotherapy in Esophageal Squamous Cell Cancer. Diagnostics 15(6):690. https:\/\/doi.org\/10.3390\/diagnostics15060690","journal-title":"Diagnostics"},{"issue":"11","key":"2614_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112967","volume":"15","author":"A Secerov Ermenc","year":"2023","unstructured":"Secerov Ermenc A, Segedin B (2023) The Role of MRI and PET\/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers\u2014Review of the Literature. Cancers 15(11):2967. https:\/\/doi.org\/10.3390\/cancers15112967","journal-title":"Cancers"},{"key":"2614_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.844702","volume":"12","author":"F Wang","year":"2022","unstructured":"Wang F, Guo R, Zhang Y, Yu B, Meng X, Kong H, et al (2022) Value of 18F-FDG PET\/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With 18F-FDG PET\/CT, MRI, and Contrast-Enhanced CT. Front Oncol 12:844702. https:\/\/doi.org\/10.3389\/fonc.2022.844702 PubMed PMID: 35296000; PubMed Central PMCID: PMC8919030.","journal-title":"Front Oncol"},{"key":"2614_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/nm9.0000000000000042","author":"H Maruyama","year":"2025","unstructured":"Maruyama H, Sato K, Takanami K, Watabe H, Kawakami H, Taniyama Y, et al (2025) Usefulness of Dynamic FDG PET\/CT in Detecting Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma Using a Silicon Photomultiplier PET Scanner. Clinical Nuclear Medicine Open 2(3). https:\/\/doi.org\/10.1097\/nm9.0000000000000042","journal-title":"Clin Nucl Med Open"},{"issue":"20","key":"2614_CR7","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.21037\/atm-21-4926","volume":"9","author":"S Liao","year":"2021","unstructured":"Liao S, Wei W, Zhang S, Zeng T, Chen H, Zheng W, et al. Modified method to improve the diagnostic efficiency of 18F-FDG PET\/CT in regional lymph node metastasis of esophageal squamous cell carcinoma. Ann Transl Med 9(20):1549\u20131549. https:\/\/doi.org\/10.21037\/atm-21-4926","journal-title":"Ann Transl Med"},{"issue":"5","key":"2614_CR8","doi-asserted-by":"publisher","first-page":"12413","DOI":"10.1097\/JS9.0000000000004815","volume":"112","author":"Y Li","year":"2026","unstructured":"Li Y, Zhang Y (2026) Response to commentary on predictive modeling for cervical lymph node metastasis in esophageal squamous cell carcinoma. International Journal of Surgery 112(5):12413\u20134. https:\/\/doi.org\/10.1097\/JS9.0000000000004815","journal-title":"Int J Surg"},{"key":"2614_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.814238","volume":"12","author":"L Chu","year":"2022","unstructured":"Chu L, Liu S, Guo T, Zou L, Li B, Ni J, et al (2022) Is Performance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography\/Computed tomography (CT) or Contrast-enhanced CT Efficient Enough to Guide the Hilar Lymph Node Staging for Patients with Esophageal Squamous Cell Carcinoma? Front Oncol 12:814238. https:\/\/doi.org\/10.3389\/fonc.2022.814238","journal-title":"Front Oncol"},{"issue":"9","key":"2614_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00066-020-01630-y","volume":"196","author":"S M\u00fcnch","year":"2020","unstructured":"M\u00fcnch S, Marr L, Feuerecker B, Dapper H, Braren R, Combs SE, et al (2020) Impact of 18F-FDG-PET\/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients. Strahlenther Onkol 196(9):787\u201394. https:\/\/doi.org\/10.1007\/s00066-020-01630-y PubMed PMID: 32430661; PubMed Central PMCID: PMC7449992.","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"issue":"12","key":"2614_CR11","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1245\/s10434-023-13694-y","volume":"30","author":"S Zhang","year":"2023","unstructured":"Zhang S, Sun L, Cai D, Liu G, Jiang D, Yin J, et al (2023) Development and Validation of PET\/CT-Based Nomogram for Preoperative Prediction of Lymph Node Status in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 30(12):7452\u201360. https:\/\/doi.org\/10.1245\/s10434-023-13694-y","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2614_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.2478\/raon-2024-0043","volume":"58","author":"A Secerov-Ermenc","year":"2024","unstructured":"Secerov-Ermenc A, Peterlin P, Anderluh F, But-Hadzic J, Jeromen-Peressutti A, Velenik V, et al (2024) Inter-observer variation in gross tumour volume delineation of oesophageal cancer on MR, CT and PET\/CT. Radiol Oncol 58(4):580\u20137. https:\/\/doi.org\/10.2478\/raon-2024-0043 PubMed PMID: 39362222; PubMed Central PMCID: PMC11604261.","journal-title":"Radiol Oncol"},{"key":"2614_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.817413","volume":"12","author":"F Li","year":"2022","unstructured":"Li F, Li Y, Wang X, Zhang Y, Liu X, Liu S, et al (2022) Inter-Observer and Intra-Observer Variability in Gross Tumor Volume Delineation of Primary Esophageal Carcinomas Based on Different Combinations of Diagnostic Multimodal Images. Front Oncol 12:817413. https:\/\/doi.org\/10.3389\/fonc.2022.817413","journal-title":"Front Oncol"},{"issue":"2","key":"2614_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.rcl.2020.11.008","volume":"59","author":"SL Betancourt-Cuellar","year":"2021","unstructured":"Betancourt-Cuellar SL, Benveniste MFK, Palacio DP, Hofstetter WL (2021) Esophageal Cancer. Radiologic Clinics of North America 59(2):219\u201329. https:\/\/doi.org\/10.1016\/j.rcl.2020.11.008","journal-title":"Radiol Clin North Am"},{"issue":"5","key":"2614_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4103\/ijnm.ijnm_118_23","volume":"39","author":"S Kommi","year":"2024","unstructured":"Kommi S, Rallapeta RP, Subramanian BV, Yadagiri LA, Hulikal N, Chandramaliteeswaran C, et al (2024) Utility of [18F]FDG- PET\/CT in Initial Staging and Management of Patients with Esophageal Carcinoma: A Tertiary Care Center Experience. Indian Journal of Nuclear Medicine 39(5):329\u201334. https:\/\/doi.org\/10.4103\/ijnm.ijnm_118_23","journal-title":"Indian J Nucl Med"},{"key":"2614_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.772428","volume":"11","author":"H Li","year":"2021","unstructured":"Li H, Li J, Li F, Zhang Y, Li Y, Guo Y, et al (2021) Geometrical Comparison and Quantitative Evaluation of 18F-FDG PET\/CT- and DW-MRI-Based Target Delineation Before and During Radiotherapy for Esophageal Squamous Carcinoma. Front Oncol 11:772428. https:\/\/doi.org\/10.3389\/fonc.2021.772428","journal-title":"Front Oncol"},{"issue":"24","key":"2614_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026338","volume":"100","author":"TH Lee","year":"2021","unstructured":"Lee TH, Ryoo HG, Lee R, Paeng JC, Chung H, Kim HJ (2021) Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer. Medicine (Baltimore) 100(24):e26338. https:\/\/doi.org\/10.1097\/MD.0000000000026338 PubMed PMID: 34128879; PubMed Central PMCID: PMC8213324.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2614_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.ijrobp.2015.03.030","volume":"92","author":"AJ Wu","year":"2015","unstructured":"Wu AJ, Bosch WR, Chang DT, Hong TS, Jabbour SK, Kleinberg LR, et al (2015) Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. Int J Radiat Oncol Biol Phys 92(4):911\u201320. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.030 PubMed PMID: 26104943; PubMed Central PMCID: PMC4481325.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2614_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00066-020-01701-0","volume":"197","author":"F Walter","year":"2021","unstructured":"Walter F, Jell C, Zollner B, Andrae C, Gerum S, Ilhan H, et al (2021) [F18] FDG-PET\/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful? Strahlenther Onkol 197(9):780\u201390. https:\/\/doi.org\/10.1007\/s00066-020-01701-0 PubMed PMID: 33104815; PubMed Central PMCID: PMC8397654.","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"2614_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.550100","volume":"11","author":"J Shi","year":"2021","unstructured":"Shi J, Li J, Li F, Zhang Y, Guo Y, Wang W, et al (2021) Comparison of the Gross Target Volumes Based on Diagnostic PET\/CT for Primary Esophageal Cancer. Front Oncol 11:550100. https:\/\/doi.org\/10.3389\/fonc.2021.550100","journal-title":"Front Oncol"},{"issue":"1","key":"2614_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01788-4","volume":"16","author":"C P\u00f6ttgen","year":"2021","unstructured":"P\u00f6ttgen C, Gkika E, Stahl M, Abu Jawad J, Gauler T, Kasper S, et al (2021) Dose-escalated radiotherapy with PET\/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3\/T4) squamous cell cancer of the esophagus: mature results of a phase I\/II trial. Radiat Oncol 16(1):59. https:\/\/doi.org\/10.1186\/s13014-021-01788-4 PubMed PMID: 33757534; PubMed Central PMCID: PMC7988964.","journal-title":"Radiat Oncol"},{"issue":"9","key":"2614_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00066-021-01761-w","volume":"197","author":"FEM Voncken","year":"2021","unstructured":"Voncken FEM, Vegt E, Van Sandick JW, Van Dieren JM, Grootscholten C, Bartels-Rutten A, et al (2021) Motion-compensated FDG PET\/CT for oesophageal cancer. Strahlenther Onkol 197(9):791\u2013801. https:\/\/doi.org\/10.1007\/s00066-021-01761-w","journal-title":"Strahlenther Onkol"},{"key":"2614_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626275","volume":"11","author":"R Innocente","year":"2021","unstructured":"Innocente R, Navarria F, Petri R, Palazzari E, Vecchiato M, Polesel J, et al (2021) Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer. Front Oncol 11:626275. https:\/\/doi.org\/10.3389\/fonc.2021.626275","journal-title":"Front Oncol"},{"issue":"5","key":"2614_CR24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.4103\/jcrt.jcrt_382_22","volume":"18","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Fan B, Sun T, Xu J, Yin Y, Chen Z, et al (2022) The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET\/CT guided in esophageal cancer. J Cancer Res Ther 18(5):1261\u20137. https:\/\/doi.org\/10.4103\/jcrt.jcrt_382_22 PubMed PMID: 36204871.","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"2614_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.radmp.2021.04.002","volume":"2","author":"B Fan","year":"2021","unstructured":"Fan B, Li C, Mu F, Qin W, Wang L, Sun X, et al (2021) Dose escalation guided by 18F-FDG PET\/CT for esophageal cancer. Radiation Medicine and Protection 2(2):55\u201360. https:\/\/doi.org\/10.1016\/j.radmp.2021.04.002","journal-title":"Radiat Med Prot"},{"key":"2614_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2020.101909","volume":"68","author":"D Jin","year":"2021","unstructured":"Jin D, Guo D, Ho TY, Harrison AP, Xiao J, Tseng C kan, et al (2021) DeepTarget: Gross tumor and clinical target volume segmentation in esophageal cancer radiotherapy. Medical Image Analysis 68:101909. https:\/\/doi.org\/10.1016\/j.media.2020.101909","journal-title":"Med Image Anal"},{"key":"2614_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.799207","volume":"12","author":"Y Yue","year":"2022","unstructured":"Yue Y, Li N, Shahid H, Bi D, Liu X, Song S, et al (2022) Gross Tumor Volume Definition and Comparative Assessment for Esophageal Squamous Cell Carcinoma From 3D 18F-FDG PET\/CT by Deep Learning-Based Method. Front Oncol 12:799207. https:\/\/doi.org\/10.3389\/fonc.2022.799207","journal-title":"Front Oncol"},{"key":"2614_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.785788","volume":"11","author":"X Ye","year":"2022","unstructured":"Ye X, Guo D, Tseng CK, Ge J, Hung TM, Pai PC, et al (2022) Multi-Institutional Validation of Two-Streamed Deep Learning Method for Automated Delineation of Esophageal Gross Tumor Volume Using Planning CT and FDG-PET\/CT. Front Oncol 11:785788. https:\/\/doi.org\/10.3389\/fonc.2021.785788","journal-title":"Front Oncol"},{"issue":"3","key":"2614_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10388-019-00704-w","volume":"17","author":"K Shuto","year":"2020","unstructured":"Shuto K, Kono T, Shiratori T, Akutsu Y, Uesato M, Mori M, et al (2020) Diagnostic performance of diffusion-weighted magnetic resonance imaging in assessing lymph node metastasis of esophageal cancer compared with PET. Esophagus 17(3):239\u201349. https:\/\/doi.org\/10.1007\/s10388-019-00704-w PubMed PMID: 31820208; PubMed Central PMCID: PMC7316698.","journal-title":"Esophagus Off J Jpn Esophageal Soc"},{"issue":"9","key":"2614_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309653","volume":"19","author":"X Sun","year":"2024","unstructured":"Sun X, Niwa T, Kazama T, Okazaki T, Koyanagi K, Kumaki N, Hashimoto J, Ozawa S (2024) Preoperative dual-energy computed tomography and positron-emission tomography evaluation of lymph node metastasis in esophageal squamous cell carcinoma. PLoS One 19(9):e0309653. https:\/\/doi.org\/10.1371\/journal.pone.0309653. PMID: 39302928; PMCID: PMC11414887.","journal-title":"PLOS ONE"},{"issue":"10","key":"2614_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/MNM.0000000000002013","volume":"46","author":"Y Li","year":"2025","unstructured":"Li Y, Wang J, Hui J, Zhang W, He W, Wei Y, et al (2025) Clinical value of multiparameters of 2-[ 18 F]-fluoro-2-deoxy-glucose PET\/MRI in tumor\/lymph node staging of esophageal squamous cell carcinoma. Nucl Med Commun 46(10):929\u201338. https:\/\/doi.org\/10.1097\/MNM.0000000000002013 PubMed PMID: 40625143; PubMed Central PMCID: PMC12422628.","journal-title":"Nucl Med Commun"},{"issue":"1","key":"2614_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-023-02224-5","volume":"18","author":"L Xia","year":"2023","unstructured":"Xia L, Li X, Zhu J, Gao Z, Zhang J, Yang G, et al (2023) Prognostic value of baseline 18F-FDG PET\/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy. Radiat Oncol 18(1):41. https:\/\/doi.org\/10.1186\/s13014-023-02224-5 PubMed PMID: 36829219; PubMed Central PMCID: PMC9960216.","journal-title":"Radiat Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02614-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:35:44Z","timestamp":1791736544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02614-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,11]]},"references-count":32,"alternative-id":["2614"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02614-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,11]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Institutional Ethics Committee of Rajiv Gandhi Cancer Institute and Research Centre, New Delhi. The requirement for written informed consent was waived by the same committee given the retrospective design and the use of anonymized, previously acquired clinical and imaging data, in accordance with institutional policy. All procedures were performed in accordance with institutional guidelines and with the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No individually identifiable patient data or images are included in this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.R.\u00a0Bellige, S.\u00a0Jain, B.\u00a0Maheshwari, S.\u00a0Tandon, A.\u00a0Nayak, A.\u00a0Bhadri, S.\u00a0Pandey, P.\u00a0Ahlawat, and M.\u00a0Gairola declare that they have no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}